Bringing proteins together to take cancer apart
At Novartis Biomedical Research, oncology teams around the world are taking on some of the biggest challenges in…
Cancer can kill you in a year. I found out the hard way what that’s like.
In the fall of 2022, when I was 42 and living with my wife and three young kids…
Higher intake of ultra processed foods linked to weaker bones
From flavored yogurts to frozen pizzas, breakfast cereals and instant oats, ultra-processed foods are convenient, often cheaper items…
International urology conference showcases advancements in prostate cancer diagnostics
Nearly 300 abstracts on prostate cancer research from around the world will be presented at the European Association…
Simplified nanoparticles “educate” the immune system to find and destroy disease-causing cells
Johns Hopkins Medicine scientists say they have developed a simplified version of biodegradable nanoparticles that can “educate” the…
Dual-positive hybrid cells linked to shorter survival in advanced breast cancer
An enigmatic type of circulating tumor cell called a dual-positive (DP) cell is associated with shorter survival time…
Foundation offers patients help with cost of cancer medications | Local News
Post-treatment cancer patients can qualify for up to $2,500 in medication assistance through a new program launched by…
Disrupting protein production in tumors triggers potent immune responses
A new study led by Pierre Close’s team (GIGA, Laboratory of Cancer Signaling, and WELRI Investigator) reveals how…
Geographic location strongly influences stage of breast cancer diagnosis
Where a woman lives significantly affects whether her breast cancer is diagnosed at an early or late stage,…
Boron-assisted reactions overcome solubility barriers in protein synthesis
Chemists from ETH Zurich have found a way to produce poorly soluble proteins by caging a uniquely reactive…
Low baseline testosterone predicts aggressive prostate cancer progression risk
A new study led by researchers at The University of Texas MD Anderson Cancer Center found that prostate cancer patients with low testosterone levels may have a higher risk of cancer progressing to a more aggressive form while under active surveillance. …
Targeting IGF2BP2 improves anti-angiogenic therapy effectiveness in colorectal cancer
A recent study published in Engineering has shed light on a novel therapeutic target for improving anti-angiogenic treatment…